ch14.18/CHO
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ch14.18/CHO, covering 2021-10-04 to 2021-10-04. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of Monoclonal Antibody ch14.18/CHO Continuous Infusion in Patients With Primary Refractory or Relapsed Neuroblastoma [Phase 2]